Monday, March 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Industry News

Notable Contracts: Mapp Biopharmaceutical, GSK, Battelle

by Global Biodefense Staff
June 17, 2014

The U.S. federal government has recently awarded several notable contracts related to the field of chemical, biological, radiological and nuclear (CBRN) countermeasures or life science research of interest for potential applications in biodefense:

Mapp Biopharmaceutical, Inc., San Diego, California, is being awarded an $8,152,103 cost- plus-fixed-fee contract for the development of a broad-spectrum monoclonal cocktail for prevention of VEEV, WEEV and EEEV, in support of the research and development enterprise. Work will be performed in San Diego, California, and various subcontractor locations; work is expected to be completed May 2017. Bids were solicited and nine were received. The contracting activity is Defense Threat Reduction Agency, Fort Belvoir, Virginia (HDTRA1-14-C-0115).

GlaxoSmithKline, Research Triangle Park, North Carolina, has been awarded a maximum $17,616,339 firm-fixed-price contract for flu vaccines. This contract was a competitive acquisition with four offers received. This is a one-year base contract with no option periods. Location of performance is North Carolina with a Sept. 30, 2015, performance completion date. Using military service is Army, Navy, Air Force, Marine Corps, and federal civilian agencies. Type of appropriation is fiscal 2014 through fiscal 2015 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania (SPE2DP-14-D-0005).

Sanofi Pasteur, Swiftwater, Pennsylvania, has been awarded a maximum $8,969,432 firm-fixed-price contract for flu vaccines. This contract was a competitive acquisition with four offers received. This is a one-year base contract with no option periods. Location of performance is Pennsylvania with a Sept. 30, 2015, performance completion date. Using military service is Army, Navy, Air Force, Marine Corps, and federal civilian agencies. Type of appropriation is fiscal 2014 through fiscal 2015 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania (SPE2DP-14-D-0004).

Alion Science and Technology, Burr Ridge, Illinois (FA8075-14-D-0014); Battelle Memorial Institute, Columbus, Ohio (FA8075-14-D-0015); Booz Allen Hamilton, McLean, Virginia (FA8075-14-D-0016); EOIR Technologies, Inc., Fredericksburg, Virginia (FA8075-14-D-0017); Georgia Tech Research Institute, Atlanta, Georgia (FA8075-14-D-0018); MacAulay-Brown, Inc., Dayton, Ohio (FA8075-14-D-0019); Mantech TSG-2 Joint Venture, Fairfax, Virginia (FA8075-14-D-0020); Prescient Edge Corporation, McLean, Virginia (FA8075-14-D-0021); Strategic Analysis, Inc., Arlington, Virginia (FA8075-14-D-0022); TASC, Inc., Andover, Maryland (FA8075-14-D-0023); URS Federal Services, Inc., Germantown, Maryland (FA8075-14-D-0024); and Wyle Laboratories, Inc., Huntsville, Alabama (FA8075-14-D-0025) have been awarded a maximum $3,000,000,000 cost-plus-fixed-fee, firm-fixed-price, multiple-award, indefinite-delivery/indefinite-quantity contract for Defense Systems Technical Area Tasks (DS TATs).

The DS TATs contracts will provide research, development, test and evaluation, and advisory and assistance services related to research and development efforts for technical area tasks within the Advanced Materials; Autonomous Systems; Directed Energy; Energetics; Military Sensing; Non-Lethal Weapons and Information Operations; Reliability, Maintainability, Quality, Supportability, and Interoperability; Survivability and Vulnerability; and Weapons Systems focus areas. Location of performance will be cited on individual task orders. Generally, work will be performed at government facilities, and the period of performance is five years.

The ordering period is a one year basic period with four one-year option periods with work expected to be completed by June 2019 if all option periods are exercised. Individual task orders, obligating fiscal 2014 research and development funds, will be issued against the basic contracts, in order to meet the minimum order guarantee of $2,500. The multiple-award contracts were competitively procured by full and open competition along with a partial small business set-aside via the Federal Business Opportunities website with 12 offers received. The Air Force Installation Contracting Agency, Offutt Air Force Base, Nebraska, is the contracting activity.

Source: Defense.gov

Tags: AntiviralsAwardsBattelleEquine EncephalitisInfluenzaVaccines

Related Posts

small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development
Industry News

DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development

January 10, 2023
Bavarian Nordic to Supply Additional Monkeypox Vaccine to EU Member States
Industry News

Bavarian Nordic to Supply Additional Monkeypox Vaccine to EU Member States

September 7, 2022
Arcturus Awarded $63.2M to Advance Self-amplifying mRNA Vaccine for Pandemic Influenza Response
Industry News

Arcturus Awarded $63.2M to Advance Self-amplifying mRNA Vaccine for Pandemic Influenza Response

August 31, 2022
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC